FindTrial
Sign In

The research on the dynamics of subpatellar fat pad in patients with knee osteoarthritis based on musculoskeletal ultrasound

The research on the dynamics of subpatellar fat pad in patients with knee osteoarthritis based on musculoskeletal ultrasound - Research on the dynamics of subpatellar fat pad in KOA by ultrasonography

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300069880
Enrollment
Unknown
Registered
2023-03-28
Start date
2023-04-15
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

knee osteoarthritis

Interventions

Single group:uninvolved

Sponsors

Affiliated Hospital of Southwest Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria of Osteoarthritis Diagnosis and Treatment Guidelines (2018 edition) : (1) Recurring knee pain within a month (2) Radiographs (standing or weight-bearing position) showing joint space narrowing, subchondral osteosclerosis and/or cystic changes, and joint margin osteophytes (3) Aged >=50 years (4) Morning stiffness <=30 minutes (5) Bone frictional sound (sensation) Meet the diagnostic criteria (1) + ((2), (3), (4), (5) of any of the 2) in the diagnosis of knee osteoarthritis. 2. Aged 40-75 years 3. 0 < VAS score <=7 4. Kellgren/Lawrence (K/L) grade of X-ray film of knee joint was I-III, and the ADL score was above 60.

Exclusion criteria

Exclusion criteria: 1. Unable or unwilling to cooperate with following-up due to objective conditions; 2. Unable to cooperate with intervention and follow-up due to cognitive decline or impairment (Montreal cognitive assessment MoCA < 18); 3. Unable to cooperate with intervention and follow up due to mental and psychological abnormalities; 4. Patients with organic diseases of cardiovascular system and respiratory system, such as coronary heart disease, COPD, emphysema, pulmonary heart disease, etc.; 5. With neurological diseases, such as cerebral infarction, cerebral hemorrhage, Parkinson's disease, balance dysfunction (orthostatic balance <= level 2), etc.; 6. After hip, knee and ankle joint replacement or fracture; 7. Abnormal or malformed ankle joint, such as pronation, pronation, high arch, flat foot, heel eversion, etc.; 8. Acute phase of knee osteoarthritis; 9. Patients who have been injected with sodium hyaluronate or steroidal anti-inflammatory drugs in the last 3 months.

Design outcomes

Primary

MeasureTime frame
WOMAC;Superficial subpatellar fat pad thickness;—

Countries

China

Contacts

Public ContactYiqin Zhang

Affiliated Hospital of Southwest Medical University

251444826@qq.com18715785826

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026